Immunize.org has been refreshed! Take a tour.
Issue 1,617: February 23, 2022
(Formerly IAC Express)
Top Stories
 
Featured Resources
 
Notable Publications
 
Upcoming Events
 
Top Stories

2022 U.S. recommended immunization schedule for children and teens released along with MMWR article detailing changes

On February 18, CDC posted the 2022 recommended immunization schedules for children and adolescents on CDC's Immunization Schedules for Healthcare Providers web page.

The updated schedules for children and adolescents include: 

Access the full-color, 10-page PDF of the child/adolescent schedule.

View what has changed on the child/adolescent schedule for 2022

As it does each year, Immunize.org will be producing sturdy, waterproof, laminated copies of these schedules for sale in coming weeks. Pre-ordering information will be shared soon in a special Shop Edition of IZ Express. 

Related Links


2022 U.S. recommended immunization schedule for adults released along with MMWR article detailing changes

On February 18, CDC also posted the 2022 recommended immunization schedules for adults on CDC's Immunization Schedules for Healthcare Providers web page.

The updated schedule for adults includes:

Access the full-color, 8-page PDF of the adult schedule.

View what has changed on the adult schedule for 2022.  

As it does each year, Immunize.org will be producing sturdy, waterproof, laminated copies of these schedules for sale in coming weeks. Pre-ordering information will be shared soon in a special Shop Edition of IZ Express.

Related Links


Immunize.org launches new “Ask the Experts: Dengue” section  

Who should get Dengvaxia? Why do you need a blood test before vaccination? Read answers to these and many other dengue vaccination questions in Immunize.org's new section of its popular Ask the Experts site.

The Ask the Experts: Dengue web page addresses important questions about dengue and dengue vaccination (Dengvaxia, Sanofi Pasteur), likely to arise in clinical and public health settings.

Immunize.org's Ask the Experts main page leads you to 30 distinct web pages on a variety of topics with more than 1,000 common or challenging questions and answers (Q&As) about vaccines and their administration. Immunize.org's team of experts includes Kelly L. Moore, MD, MPH (team lead), Carolyn B. Bridges, MD, FACP, and Iyabode Beysolow, MD, MPH.

Dengue is an infectious disease caused by four types of dengue viruses (DENVs), which are predominantly transmitted by Aedes aegypti and Aedes albopictus mosquitos. Areas where dengue is endemic in United States territories and freely associated states include Puerto Rico, American Samoa, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of Marshall Islands, and the Republic of Palau.
 
In December 2021, ACIP published its recommendations for the routine use of Dengvaxia (Sanofi Pasteur) for the prevention of dengue in children ages 9 through 16 years with evidence of previous dengue virus infection who live in areas where dengue is endemic. Dengvaxia is recommended as a 3-dose vaccination series, administered 6 months apart at 0, 6, and 12 months, for the selected pediatric population. Evidence of previous dengue infection, such as confirmation with previous laboratory-confirmed infection or a highly specific serodiagnostic test, is required among eligible children before vaccination.
 
To learn more about Dengvaxia and its use, visit Ask the Experts: Dengue web page.
 
Related Links

Back to top
 
“Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine during Pregnancy against COVID-19–Associated Hospitalization in Infants Aged <6 Months—17 States, July 2021–January 2022” published in MMWR

CDC published Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine during Pregnancy against COVID-19–Associated Hospitalization in Infants Aged <6 Months—17 States, July 2021–January 2022 in the February 18 issue of MMWR. A portion of the summary appears below.

Completion of a 2-dose mRNA COVID-19 vaccination series during pregnancy might help prevent COVID-19 hospitalization among infants aged <6 months.

Access the MMWR article in HTML or  PDF.

Related Link

Back to top
 


ACOG releases two videos encouraging COVID-19 vaccination during pregnancy

The American College of Obstetricians and Gynecologists (ACOG) has released two new videos encouraging COVID-19 vaccination during pregnancy.

The first video encourages all people who are pregnant, thinking about becoming pregnant, and lactating to get vaccinated against COVID-19. This public service announcement (PSA) is designed for multiple platforms including TV, radio, social media, and websites. 

The second video supports clinicians and partners in counseling their patients to get vaccinated against COVID-19.  This PSA is designed to be shared on clinician websites and via social media. 

Related Link


Sporadic flu activity continues across the country; vaccinate as long as influenza is a threat in your community

Influenza Surveillance
For week 6, ending on February 12, CDC's Weekly U.S. Influenza Surveillance Report, FluView summary reports sporadic influenza activity continues across the country. The percentage of outpatient visits due to respiratory illness has decreased nationally and is below baseline. CDC estimates that so far this season there have been at least 2.2 million flu illnesses, 22,000 hospitalizations, and 1,300 deaths from flu.

Influenza Vaccination Dashboard
CDC's new Weekly Flu Vaccination Dashboard shares preliminary vaccination data. This week’s key fact: flu vaccination coverage is 2.8 percentage points lower for all children this season (as of week ending January 8, 2022) compared with last season (as of week ending January 9, 2021) (50.3% compared to 53.1%).

CDC recommends everyone age 6 months and older get an annual flu vaccine. Influenza and COVID-19 vaccines may be given at the same visit, if needed. COVID-19 vaccination alone provides no protection from influenza or any other respiratory virus. 

Vaccine Finder
If you don’t provide influenza vaccine at your site, please strongly recommend vaccination and refer people to sites that do vaccinate. Use VaccineFinder, a user-friendly website to help people of all ages find influenza, COVID-19, and other vaccines. Participating providers can update their vaccine inventory estimates on VaccineFinder. For questions or more information, contact vaccine@healthmap.org.

Related Links


Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 545 institutions. Five previously honored institutions qualify for additional years' honors.

Immunize.org is pleased to announce the renewal of five institutions into its Hepatitis B Birth Dose Honor Roll, with a total of 545 honorees. The birthing institutions are listed below with their reported hepatitis B birth dose coverage rates in parentheses.

One institution is being recognized for a second year:
  • Shannon Medical Center South, San Angelo, TX (95%)
One institution is being recognized for a fifth year:
  • Greene County General Hospital, Linton, IN (91%)
One institution is being recognized for a sixth year:
  • Olivia Hospital & Clinic, Olivia, MN (91%)
Finally, two institutions are being recognized for a seventh year:
  • MetroHealth Medical Center, Cleveland, OH (90%)
  • Shannon Medical Center, San Angelo, TX (98%)

The Honor Roll now includes 545 birthing institutions from 44 states, the District of Columbia, Puerto Rico, Guam, Saipan, and a U.S. military base in England. One hundred twenty-three institutions have qualified for 2 years, 73 institutions have qualified three times, 41 institutions have qualified four times, 25 institutions have qualified five times, 22 institutions have qualified six times, eleven institutions have qualified seven times, two institutions have qualified eight times and one institution has qualified nine times.

The Honor Roll is a key part of Immunize.org’s major initiative urging the nation’s hospitals to Give Birth to the End of Hep B. Hospitals and birthing centers are recognized for attaining high coverage rates for administering hepatitis B vaccine at birth and meeting specific additional criteria. The initiative urges qualifying healthcare organizations to apply for the Hepatitis B Birth Dose Honor Roll online.

To be included in the Hepatitis B Birth Dose Honor Roll, a birthing institution must have: (1) reported a coverage rate of 90% or greater, over a twelve-month period, for administering hepatitis B vaccine before hospital discharge to all newborns, including those whose parents refuse vaccination, and (2) implemented specific written policies, procedures, and protocols to protect all newborns from hepatitis B virus infection before hospital discharge.

Honorees are also awarded an 8.5" x 11" color certificate suitable for framing and their acceptance is announced to IZ Express’s 53,000+ readers.

Please visit the Hepatitis B Birth Dose Honor Roll web page that lists these institutions and their exceptional efforts to protect infants from perinatal hepatitis B transmission.

Related Immunize.org Resources


Spotlight! Immunize.org’s "Handouts" main page provides free access to hundreds of vaccination-related handouts and fact sheets

Immunize.org's Handouts for Patients and Staff web page leads users to hundreds of free vaccination-related patient handouts and fact sheets for healthcare professionals. All items are ready to print, copy, and distribute widely.

Visit the Handouts for Patients and Staff web page to view more than 230 handouts sorted by:

From the main page, you can search on any of the 22 topics. Some of the most popular are:

The right-hand side of the web page includes links to some of Immunize.org's most popular handouts, including:

You can also view an alphabetical listing of Immunize.org’s more than 230 ready-to-print staff educational materials and patient handouts.

Visit Immunize.org's Handouts for Patients and Staff web page today!


Vaccines in the news

These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.


Featured Resources

65+ Flu Defense website offers resources for healthcare professionals serving older adults

Confident recommendations for influenza vaccine from healthcare providers are powerfully persuasive. To assist you in maximizing protection for your patients, Immunize.org, in collaboration with Seqirus, has updated the 65+ Flu Defense website at www.influenza-defense.org.

A new fact sheet on the site, The Importance of Preventing Influenza during a Pandemic, offers responses to help guide discussions with patients on the increased importance of flu vaccination during the COVID-19 pandemic. Age increases risks associated with COVID-19 infection including hospitalization and death. Preliminary studies suggest coinfection with influenza B and SARS-CoV-2 may elevate the risk of poor outcomes.

This helpful site includes information, tools, and tips for communicating with these adults about the scope and severity of influenza, for example:

Check out the updated 65+ Flu Defense website at www.influenza-defense.org to assist your efforts in protecting this vulnerable population.


FREE! Immunize.org offers COVID-19 and flu buttons and stickers. Place your order now!

Kids love stickers! As COVID-19 vaccination programs vaccinate children age 5 and older and offer booster doses to more people, now is the time to stock up on Immunize.org’s FREE “I Got My COVID-19 Vaccine” stickers, provided at no cost for product or shipping thanks to support from CDC. Stickers are available in English and Spanish. These stickers are perfect for people of all ages who want to show their confidence in COVID-19 vaccination. 

Click the picture to place your order now:

Immunize.org also has a limited supply of our popular “Vacuna Contra LA GRIPE” buttons and stickers, available at no charge for product or shipping, thanks to funding from Seqirus. Now more than ever, it is important to step up our efforts to eliminate disparities in influenza vaccination rates. This bright red Spanish button can help. 

Click the picture to place your order now:

For clinics serving Spanish-speaking communities, this is a great opportunity to order an ample supply of La Gripe buttons and stickers as you prepare for the next influenza season.


Immunize.org's elegantly designed “Vaccines Save Lives” black enamel pins make wonderful gifts or workplace recognitions

Immunize.org’s elegantly designed “Vaccines Save Lives” pins are meaningful gifts for people who care about vaccination. The pin makes a refined statement in hard black enamel with gold lettering and edges, measuring 1.125" x 0.75".

The pin is a stick-through-post variety with the back end covered by a round rubber cap that holds the pin securely. A gold metal spring-lock clasp is also provided.

Wear these pins on clothing, uniforms, and white coats to show that you value vaccines!

  

Click here for "Vaccines Save Lives" pin pricing and ordering information.


Notable Publications

“Outbreak of COVID-19 among a Highly Vaccinated Population aboard a U.S. Navy Ship after a Port Visit—Reykjavik, Iceland, July 2021” published in MMWR

CDC published Notes from the Field: Outbreak of COVID-19 among a Highly Vaccinated Population aboard a U.S. Navy Ship after a Port Visit—Reykjavik, Iceland, July 2021 on February 18 in MMWR. A portion of the article appears below. 

This outbreak in the enclosed environment of a ship suggests that high vaccination rates, in combination with COVID-19 prevention measures, can substantially reduce the spread of SARS-CoV-2, despite the high transmissibility of the Delta variant and introduction of SARS-CoV-2 into a congregate setting. Infections among vaccinated persons did occur, which is expected, but symptoms were mild. Vaccination, in coordination with multicomponent prevention strategies, are critical to limiting SARS-CoV-2 transmission and COVID-19–related illness.

Access the MMWR article in HTML or PDF.

Related Link


"mRNA Vaccine-Induced Antibodies More Effective than Natural Immunity in Neutralizing SARS-CoV-2 and Its High Affinity Variants" published in Scientific Reports

In the February 16 issue, Scientific Reports published mRNA Vaccine-Induced Antibodies More Effective than Natural Immunity in Neutralizing SARS-CoV-2 and Its High Affinity Variants. A portion of the abstract appears below.

...our data indicates that mRNA vaccination may generate more neutralizing RBD [receptor-binding domain] antibodies than natural immunity. It further suggests a potential need to maintain high RBD antibody levels to control the more infectious SARS-CoV-2 variants.


MMWR Recap: Articles regarding COVID-19 vaccine effectiveness and safety monitoring

CDC recently published several articles first distributed as MMWR Early Releases:

  • Safety Monitoring of COVID-19 Vaccine Booster Doses among Adults—United States, September 22, 2021–February 6, 2022 (MMWR, February 18, HTML or PDF)
  • Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations among Adults during Periods of Delta and Omicron Variant Predominance—VISION Network, 10 States, August 2021–January 2022 (MMWR, February 18, HTML or PDF)
Related Link
  • MMWR main page provides access to MMWR Weekly and its companion publications

Upcoming Events

Today! Wednesday–Thursday, February 23–24: ACIP meeting on tick-borne encephalitis, cholera, influenza, MMR, and pneumococcal vaccines

CDC will convene its Advisory Committee on Immunization Practices (ACIP) today, February 23, from 10:00 a.m.–3:40 p.m. (ET) and tomorrow, February 24, from 10:00 a.m.–12:25 p.m. (ET). The meeting will include discussion of tick-borne encephalitis, cholera, influenza, measles-mumps-rubella (MMR), and pneumococcal vaccines.

No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for public comment are described at the website.

View the agenda.

Related Links


For more upcoming events, visit our Calendar of Events.
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles. When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue.

IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .